Skip to content
The Nexus
BUSINESSAug 5 · 09:08 UTCBLOOMBERG

Novo Not Discussing Further Pill Discounts, CEO Says

Novo Nordisk CEO Mike Doustdar stated the company is not currently discussing further discounts for its Wegovy weight-loss pill, which underperformed sales expectations and disappointed investors.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
Novo Nordisk A/SorganizationMike DoustdarpersonWegovytopicBloombergorganizationFrancine Lacquaperson
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting